<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
EOLS
Evolus
$
()


  • Evolus discloses publication of Phase 2 study data of 40U Jeuveau

    4/17/2024 - 16:06pm
  • Evolus 3.55M share Spot Secondary priced at $14.07

    3/11/2024 - 07:25am
  • Evolus price target raised by $2 at Stifel, here's why

    3/8/2024 - 08:25am
  • Evolus price target raised by $3 at Mizuho, here's why

    3/8/2024 - 06:41am
  • Fly Intel: After-Hours Movers

    3/7/2024 - 18:04pm
  • Evolus sees FY24 revenue $255M-$265M, consensus $261.17M

    3/7/2024 - 16:30pm
  • Evolus reports Q4 EPS (21c), consensus (7c)

    3/7/2024 - 16:29pm
  • Evolus just upgraded at Barclays, here's why

    1/29/2024 - 05:52am
  • What You Missed On Wall Street On Wednesday

    1/17/2024 - 16:18pm
  • What You Missed On Wall Street This Morning

    1/17/2024 - 12:09pm
  • Fly Intel: After-Hours Movers

    1/16/2024 - 17:41pm
  • Evolus sees FY24 revenue $255M-$265M, consensus $253.27M

    1/16/2024 - 17:33pm
  • Evolus sees Q4 revenue $61M, consensus $56.97M

    1/16/2024 - 17:31pm
  • Evolus in 'dermal fillers' licensing pact with Symatese in stock and cash deal

    12/20/2023 - 08:17am
  • Evolus management to meet virtually with Mizuho

    12/11/2023 - 04:55am
dynamic_feed Breaking News